nodes	percent_of_prediction	percent_of_DWPC	metapath
Dinoprost Tromethamine—SLCO3A1—Methotrexate—bone cancer	0.336	0.432	CbGbCtD
Dinoprost Tromethamine—SLC22A2—Cisplatin—bone cancer	0.116	0.149	CbGbCtD
Dinoprost Tromethamine—SLC22A11—Methotrexate—bone cancer	0.111	0.143	CbGbCtD
Dinoprost Tromethamine—SLC22A7—Methotrexate—bone cancer	0.105	0.136	CbGbCtD
Dinoprost Tromethamine—SLC22A8—Methotrexate—bone cancer	0.0644	0.0829	CbGbCtD
Dinoprost Tromethamine—SLC22A6—Methotrexate—bone cancer	0.0448	0.0577	CbGbCtD
Dinoprost Tromethamine—Venous thrombosis—Carboplatin—bone cancer	0.00938	0.0741	CcSEcCtD
Dinoprost Tromethamine—Fluid overload—Carboplatin—bone cancer	0.00814	0.0643	CcSEcCtD
Dinoprost Tromethamine—Extravasation—Carboplatin—bone cancer	0.0058	0.0458	CcSEcCtD
Dinoprost Tromethamine—Phlebitis—Carboplatin—bone cancer	0.00427	0.0337	CcSEcCtD
Dinoprost Tromethamine—Venous thrombosis—Cisplatin—bone cancer	0.00275	0.0217	CcSEcCtD
Dinoprost Tromethamine—Fluid overload—Cisplatin—bone cancer	0.00239	0.0189	CcSEcCtD
Dinoprost Tromethamine—Infection—Carboplatin—bone cancer	0.0018	0.0142	CcSEcCtD
Dinoprost Tromethamine—Extravasation—Cisplatin—bone cancer	0.0017	0.0134	CcSEcCtD
Dinoprost Tromethamine—Pain—Carboplatin—bone cancer	0.00155	0.0122	CcSEcCtD
Dinoprost Tromethamine—Hiccups—Cisplatin—bone cancer	0.00149	0.0117	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Carboplatin—bone cancer	0.00143	0.0113	CcSEcCtD
Dinoprost Tromethamine—Venous thrombosis—Epirubicin—bone cancer	0.00141	0.0112	CcSEcCtD
Dinoprost Tromethamine—Venous thrombosis—Doxorubicin—bone cancer	0.00131	0.0103	CcSEcCtD
Dinoprost Tromethamine—Hypoxia—Methotrexate—bone cancer	0.00128	0.0101	CcSEcCtD
Dinoprost Tromethamine—Tafluprost—PTGS2—bone cancer	0.00127	1	CrCbGaD
Dinoprost Tromethamine—Phlebitis—Cisplatin—bone cancer	0.00125	0.00988	CcSEcCtD
Dinoprost Tromethamine—Cardiac failure congestive—Cisplatin—bone cancer	0.00119	0.00939	CcSEcCtD
Dinoprost Tromethamine—Burning sensation—Methotrexate—bone cancer	0.00117	0.00926	CcSEcCtD
Dinoprost Tromethamine—Cyanosis—Methotrexate—bone cancer	0.00115	0.00909	CcSEcCtD
Dinoprost Tromethamine—Hyperventilation—Epirubicin—bone cancer	0.00111	0.00875	CcSEcCtD
Dinoprost Tromethamine—Burning sensation—Epirubicin—bone cancer	0.0011	0.00867	CcSEcCtD
Dinoprost Tromethamine—Ventricular arrhythmia—Epirubicin—bone cancer	0.00103	0.00814	CcSEcCtD
Dinoprost Tromethamine—Hyperventilation—Doxorubicin—bone cancer	0.00103	0.0081	CcSEcCtD
Dinoprost Tromethamine—Burning sensation—Doxorubicin—bone cancer	0.00102	0.00802	CcSEcCtD
Dinoprost Tromethamine—Dehydration—Cisplatin—bone cancer	0.001	0.00792	CcSEcCtD
Dinoprost Tromethamine—Petechiae—Methotrexate—bone cancer	0.000991	0.00782	CcSEcCtD
Dinoprost Tromethamine—Hypokalaemia—Cisplatin—bone cancer	0.000981	0.00775	CcSEcCtD
Dinoprost Tromethamine—Ventricular arrhythmia—Doxorubicin—bone cancer	0.000954	0.00753	CcSEcCtD
Dinoprost Tromethamine—Extravasation—Methotrexate—bone cancer	0.000934	0.00738	CcSEcCtD
Dinoprost Tromethamine—Petechiae—Epirubicin—bone cancer	0.000927	0.00732	CcSEcCtD
Dinoprost Tromethamine—Extravasation—Epirubicin—bone cancer	0.000874	0.0069	CcSEcCtD
Dinoprost Tromethamine—Petechiae—Doxorubicin—bone cancer	0.000858	0.00677	CcSEcCtD
Dinoprost Tromethamine—Respiratory failure—Methotrexate—bone cancer	0.00083	0.00655	CcSEcCtD
Dinoprost Tromethamine—Pulmonary embolism—Methotrexate—bone cancer	0.000815	0.00644	CcSEcCtD
Dinoprost Tromethamine—Extravasation—Doxorubicin—bone cancer	0.000809	0.00639	CcSEcCtD
Dinoprost Tromethamine—Hiccups—Epirubicin—bone cancer	0.000763	0.00602	CcSEcCtD
Dinoprost Tromethamine—Pulmonary embolism—Epirubicin—bone cancer	0.000763	0.00602	CcSEcCtD
Dinoprost Tromethamine—Bradycardia—Cisplatin—bone cancer	0.000759	0.006	CcSEcCtD
Dinoprost Tromethamine—Sepsis—Methotrexate—bone cancer	0.000707	0.00558	CcSEcCtD
Dinoprost Tromethamine—Pulmonary embolism—Doxorubicin—bone cancer	0.000706	0.00557	CcSEcCtD
Dinoprost Tromethamine—Hiccups—Doxorubicin—bone cancer	0.000706	0.00557	CcSEcCtD
Dinoprost Tromethamine—Thrombophlebitis—Methotrexate—bone cancer	0.000684	0.0054	CcSEcCtD
Dinoprost Tromethamine—HPGDS—Biological oxidations—GSTP1—bone cancer	0.000682	0.00713	CbGpPWpGaD
Dinoprost Tromethamine—Diabetes mellitus—Methotrexate—bone cancer	0.00068	0.00537	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—GPCR ligand binding—GRM4—bone cancer	0.000677	0.00708	CbGpPWpGaD
Dinoprost Tromethamine—Immune system disorder—Cisplatin—bone cancer	0.000674	0.00532	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—GNA11—bone cancer	0.000671	0.00702	CbGpPWpGaD
Dinoprost Tromethamine—Hypertonia—Epirubicin—bone cancer	0.000669	0.00528	CcSEcCtD
Dinoprost Tromethamine—Sepsis—Epirubicin—bone cancer	0.000662	0.00523	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—Platelet activation, signaling and aggregation—GNA11—bone cancer	0.000656	0.00687	CbGpPWpGaD
Dinoprost Tromethamine—Phlebitis—Epirubicin—bone cancer	0.000643	0.00507	CcSEcCtD
Dinoprost Tromethamine—Thrombophlebitis—Epirubicin—bone cancer	0.00064	0.00505	CcSEcCtD
Dinoprost Tromethamine—Diabetes mellitus—Epirubicin—bone cancer	0.000637	0.00503	CcSEcCtD
Dinoprost Tromethamine—Muscle spasms—Cisplatin—bone cancer	0.000624	0.00493	CcSEcCtD
Dinoprost Tromethamine—Hypertonia—Doxorubicin—bone cancer	0.000619	0.00488	CcSEcCtD
Dinoprost Tromethamine—HPGDS—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	0.000613	0.00641	CbGpPWpGaD
Dinoprost Tromethamine—Sepsis—Doxorubicin—bone cancer	0.000613	0.00484	CcSEcCtD
Dinoprost Tromethamine—PTGER3—GPCR ligand binding—GRM4—bone cancer	0.000611	0.00639	CbGpPWpGaD
Dinoprost Tromethamine—Cardiac failure congestive—Epirubicin—bone cancer	0.000611	0.00482	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Cisplatin—bone cancer	0.000603	0.00476	CcSEcCtD
Dinoprost Tromethamine—SLCO2A1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000602	0.0063	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Platelet activation, signaling and aggregation—IL3—bone cancer	0.000595	0.00622	CbGpPWpGaD
Dinoprost Tromethamine—Phlebitis—Doxorubicin—bone cancer	0.000595	0.0047	CcSEcCtD
Dinoprost Tromethamine—Thrombophlebitis—Doxorubicin—bone cancer	0.000592	0.00467	CcSEcCtD
Dinoprost Tromethamine—Diabetes mellitus—Doxorubicin—bone cancer	0.000589	0.00465	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—GPCR ligand binding—GRM1—bone cancer	0.000587	0.00614	CbGpPWpGaD
Dinoprost Tromethamine—Malaise—Cisplatin—bone cancer	0.000586	0.00462	CcSEcCtD
Dinoprost Tromethamine—SLCO3A1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000571	0.00598	CbGpPWpGaD
Dinoprost Tromethamine—Cardiac failure congestive—Doxorubicin—bone cancer	0.000565	0.00446	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Cisplatin—bone cancer	0.000563	0.00444	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—Thromboxane A2 receptor signaling—EGFR—bone cancer	0.00056	0.00586	CbGpPWpGaD
Dinoprost Tromethamine—Diplopia—Epirubicin—bone cancer	0.000554	0.00437	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Cisplatin—bone cancer	0.000546	0.00431	CcSEcCtD
Dinoprost Tromethamine—GALR3—GPCR ligand binding—SMO—bone cancer	0.000533	0.00558	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR ligand binding—GRM1—bone cancer	0.00053	0.00554	CbGpPWpGaD
Dinoprost Tromethamine—Cardiac arrest—Epirubicin—bone cancer	0.000527	0.00416	CcSEcCtD
Dinoprost Tromethamine—Infection—Cisplatin—bone cancer	0.000527	0.00416	CcSEcCtD
Dinoprost Tromethamine—SLCO2A1—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.00052	0.00544	CbGpPWpGaD
Dinoprost Tromethamine—Tachycardia—Cisplatin—bone cancer	0.000517	0.00408	CcSEcCtD
Dinoprost Tromethamine—Dehydration—Epirubicin—bone cancer	0.000515	0.00407	CcSEcCtD
Dinoprost Tromethamine—Diplopia—Doxorubicin—bone cancer	0.000512	0.00405	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Cisplatin—bone cancer	0.000512	0.00405	CcSEcCtD
Dinoprost Tromethamine—PTGFR—G alpha (q) signalling events—GNA11—bone cancer	0.000506	0.00529	CbGpPWpGaD
Dinoprost Tromethamine—Hypokalaemia—Epirubicin—bone cancer	0.000504	0.00398	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Cisplatin—bone cancer	0.000495	0.00391	CcSEcCtD
Dinoprost Tromethamine—PTGER1—G alpha (q) signalling events—GNA11—bone cancer	0.000495	0.00518	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—GPCR downstream signaling—GRM4—bone cancer	0.000493	0.00516	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—GPCR downstream signaling—RGS1—bone cancer	0.000493	0.00516	CbGpPWpGaD
Dinoprost Tromethamine—SLCO3A1—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000493	0.00516	CbGpPWpGaD
Dinoprost Tromethamine—Cardiac arrest—Doxorubicin—bone cancer	0.000487	0.00385	CcSEcCtD
Dinoprost Tromethamine—Dysuria—Methotrexate—bone cancer	0.000478	0.00378	CcSEcCtD
Dinoprost Tromethamine—HPGDS—Metabolism—NDUFA12—bone cancer	0.000478	0.005	CbGpPWpGaD
Dinoprost Tromethamine—Dehydration—Doxorubicin—bone cancer	0.000477	0.00376	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Cisplatin—bone cancer	0.000476	0.00376	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Cisplatin—bone cancer	0.000473	0.00373	CcSEcCtD
Dinoprost Tromethamine—Hypokalaemia—Doxorubicin—bone cancer	0.000466	0.00368	CcSEcCtD
Dinoprost Tromethamine—PTGFR—GPCR ligand binding—GRM4—bone cancer	0.000457	0.00478	CbGpPWpGaD
Dinoprost Tromethamine—Drowsiness—Methotrexate—bone cancer	0.000456	0.0036	CcSEcCtD
Dinoprost Tromethamine—HPGDS—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	0.000455	0.00476	CbGpPWpGaD
Dinoprost Tromethamine—Pain—Cisplatin—bone cancer	0.000453	0.00358	CcSEcCtD
Dinoprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—GNA11—bone cancer	0.000453	0.00473	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—RGS1—bone cancer	0.000448	0.00469	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—GRM4—bone cancer	0.000448	0.00469	CbGpPWpGaD
Dinoprost Tromethamine—Dysuria—Epirubicin—bone cancer	0.000448	0.00353	CcSEcCtD
Dinoprost Tromethamine—PTGER1—GPCR ligand binding—GRM4—bone cancer	0.000447	0.00468	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR ligand binding—GRM4—bone cancer	0.000447	0.00468	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—GNA11—bone cancer	0.000443	0.00463	CbGpPWpGaD
Dinoprost Tromethamine—Sweating—Methotrexate—bone cancer	0.000437	0.00345	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Cisplatin—bone cancer	0.000437	0.00345	CcSEcCtD
Dinoprost Tromethamine—Haematuria—Methotrexate—bone cancer	0.000435	0.00343	CcSEcCtD
Dinoprost Tromethamine—Epistaxis—Methotrexate—bone cancer	0.00043	0.0034	CcSEcCtD
Dinoprost Tromethamine—GALR3—GPCR downstream signaling—GRM1—bone cancer	0.000428	0.00448	CbGpPWpGaD
Dinoprost Tromethamine—Drowsiness—Epirubicin—bone cancer	0.000427	0.00337	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Cisplatin—bone cancer	0.000419	0.00331	CcSEcCtD
Dinoprost Tromethamine—Urinary tract infection—Epirubicin—bone cancer	0.000415	0.00327	CcSEcCtD
Dinoprost Tromethamine—Dysuria—Doxorubicin—bone cancer	0.000414	0.00327	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—GPCR ligand binding—SMO—bone cancer	0.000414	0.00433	CbGpPWpGaD
Dinoprost Tromethamine—Sweating—Epirubicin—bone cancer	0.000409	0.00323	CcSEcCtD
Dinoprost Tromethamine—Haematuria—Epirubicin—bone cancer	0.000407	0.00321	CcSEcCtD
Dinoprost Tromethamine—Epistaxis—Epirubicin—bone cancer	0.000403	0.00318	CcSEcCtD
Dinoprost Tromethamine—HPGDS—Metabolism—NT5C3A—bone cancer	0.000396	0.00414	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR ligand binding—GRM1—bone cancer	0.000396	0.00414	CbGpPWpGaD
Dinoprost Tromethamine—Drowsiness—Doxorubicin—bone cancer	0.000395	0.00312	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Cisplatin—bone cancer	0.00039	0.00308	CcSEcCtD
Dinoprost Tromethamine—Bradycardia—Epirubicin—bone cancer	0.00039	0.00308	CcSEcCtD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—GRM1—bone cancer	0.000389	0.00406	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR ligand binding—GRM1—bone cancer	0.000388	0.00405	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR ligand binding—GRM1—bone cancer	0.000388	0.00405	CbGpPWpGaD
Dinoprost Tromethamine—Urinary tract infection—Doxorubicin—bone cancer	0.000384	0.00303	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—GPCR downstream signaling—RGS1—bone cancer	0.000383	0.004	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR downstream signaling—GRM4—bone cancer	0.000383	0.004	CbGpPWpGaD
Dinoprost Tromethamine—Asthenia—Cisplatin—bone cancer	0.00038	0.003	CcSEcCtD
Dinoprost Tromethamine—Sweating—Doxorubicin—bone cancer	0.000379	0.00299	CcSEcCtD
Dinoprost Tromethamine—Haematuria—Doxorubicin—bone cancer	0.000376	0.00297	CcSEcCtD
Dinoprost Tromethamine—PTGER3—GPCR ligand binding—SMO—bone cancer	0.000373	0.0039	CbGpPWpGaD
Dinoprost Tromethamine—Epistaxis—Doxorubicin—bone cancer	0.000372	0.00294	CcSEcCtD
Dinoprost Tromethamine—Angiopathy—Methotrexate—bone cancer	0.000371	0.00293	CcSEcCtD
Dinoprost Tromethamine—PTGIR—Thromboxane A2 receptor signaling—EGFR—bone cancer	0.00037	0.00387	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—SPARC—bone cancer	0.00037	0.00387	CbGpPWpGaD
Dinoprost Tromethamine—Immune system disorder—Methotrexate—bone cancer	0.00037	0.00292	CcSEcCtD
Dinoprost Tromethamine—Chills—Methotrexate—bone cancer	0.000367	0.0029	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Cisplatin—bone cancer	0.000363	0.00286	CcSEcCtD
Dinoprost Tromethamine—Bradycardia—Doxorubicin—bone cancer	0.000361	0.00285	CcSEcCtD
Dinoprost Tromethamine—SLC22A7—Fluoropyrimidine Activity—TP53—bone cancer	0.000351	0.00367	CbGpPWpGaD
Dinoprost Tromethamine—Angiopathy—Epirubicin—bone cancer	0.000348	0.00274	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—GRM4—bone cancer	0.000347	0.00364	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—RGS1—bone cancer	0.000347	0.00364	CbGpPWpGaD
Dinoprost Tromethamine—Immune system disorder—Epirubicin—bone cancer	0.000346	0.00273	CcSEcCtD
Dinoprost Tromethamine—PTGER3—GPCR downstream signaling—GRM4—bone cancer	0.000345	0.00361	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR downstream signaling—RGS1—bone cancer	0.000345	0.00361	CbGpPWpGaD
Dinoprost Tromethamine—Back pain—Methotrexate—bone cancer	0.000345	0.00272	CcSEcCtD
Dinoprost Tromethamine—Chills—Epirubicin—bone cancer	0.000344	0.00271	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—Hemostasis—GNA11—bone cancer	0.000338	0.00354	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	0.000337	0.00353	CbGpPWpGaD
Dinoprost Tromethamine—Vomiting—Cisplatin—bone cancer	0.000337	0.00266	CcSEcCtD
Dinoprost Tromethamine—Rash—Cisplatin—bone cancer	0.000334	0.00264	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Cisplatin—bone cancer	0.000334	0.00264	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—GPCR downstream signaling—GRM1—bone cancer	0.000332	0.00347	CbGpPWpGaD
Dinoprost Tromethamine—Ill-defined disorder—Methotrexate—bone cancer	0.000331	0.00261	CcSEcCtD
Dinoprost Tromethamine—HPGDS—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	0.000325	0.0034	CbGpPWpGaD
Dinoprost Tromethamine—Back pain—Epirubicin—bone cancer	0.000323	0.00255	CcSEcCtD
Dinoprost Tromethamine—Angiopathy—Doxorubicin—bone cancer	0.000322	0.00254	CcSEcCtD
Dinoprost Tromethamine—Malaise—Methotrexate—bone cancer	0.000321	0.00254	CcSEcCtD
Dinoprost Tromethamine—Muscle spasms—Epirubicin—bone cancer	0.000321	0.00253	CcSEcCtD
Dinoprost Tromethamine—Immune system disorder—Doxorubicin—bone cancer	0.00032	0.00253	CcSEcCtD
Dinoprost Tromethamine—Chills—Doxorubicin—bone cancer	0.000318	0.00251	CcSEcCtD
Dinoprost Tromethamine—Nausea—Cisplatin—bone cancer	0.000315	0.00249	CcSEcCtD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—RGS1—bone cancer	0.000313	0.00328	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—GRM4—bone cancer	0.000313	0.00328	CbGpPWpGaD
Dinoprost Tromethamine—Cough—Methotrexate—bone cancer	0.000311	0.00246	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Epirubicin—bone cancer	0.000309	0.00244	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Methotrexate—bone cancer	0.000309	0.00244	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—Hemostasis—IL3—bone cancer	0.000307	0.00321	CbGpPWpGaD
Dinoprost Tromethamine—Agitation—Epirubicin—bone cancer	0.000306	0.00242	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Methotrexate—bone cancer	0.000303	0.0024	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—GRM1—bone cancer	0.000301	0.00315	CbGpPWpGaD
Dinoprost Tromethamine—Malaise—Epirubicin—bone cancer	0.000301	0.00237	CcSEcCtD
Dinoprost Tromethamine—SLC22A11—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.0003	0.00314	CbGpPWpGaD
Dinoprost Tromethamine—Discomfort—Methotrexate—bone cancer	0.0003	0.00237	CcSEcCtD
Dinoprost Tromethamine—PTGER3—GPCR downstream signaling—GRM1—bone cancer	0.000299	0.00313	CbGpPWpGaD
Dinoprost Tromethamine—Syncope—Epirubicin—bone cancer	0.000299	0.00236	CcSEcCtD
Dinoprost Tromethamine—Back pain—Doxorubicin—bone cancer	0.000298	0.00236	CcSEcCtD
Dinoprost Tromethamine—Muscle spasms—Doxorubicin—bone cancer	0.000297	0.00234	CcSEcCtD
Dinoprost Tromethamine—Loss of consciousness—Epirubicin—bone cancer	0.000293	0.00231	CcSEcCtD
Dinoprost Tromethamine—HPGDS—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	0.000293	0.00306	CbGpPWpGaD
Dinoprost Tromethamine—Cough—Epirubicin—bone cancer	0.000291	0.0023	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Epirubicin—bone cancer	0.000289	0.00228	CcSEcCtD
Dinoprost Tromethamine—Infection—Methotrexate—bone cancer	0.000289	0.00228	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Epirubicin—bone cancer	0.000288	0.00227	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Doxorubicin—bone cancer	0.000286	0.00226	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Epirubicin—bone cancer	0.000284	0.00224	CcSEcCtD
Dinoprost Tromethamine—Agitation—Doxorubicin—bone cancer	0.000284	0.00224	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Methotrexate—bone cancer	0.000281	0.00222	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Epirubicin—bone cancer	0.000281	0.00221	CcSEcCtD
Dinoprost Tromethamine—PTGFR—GPCR ligand binding—SMO—bone cancer	0.000279	0.00292	CbGpPWpGaD
Dinoprost Tromethamine—Malaise—Doxorubicin—bone cancer	0.000278	0.0022	CcSEcCtD
Dinoprost Tromethamine—Syncope—Doxorubicin—bone cancer	0.000277	0.00218	CcSEcCtD
Dinoprost Tromethamine—GALR3—GPCR downstream signaling—GNA11—bone cancer	0.000276	0.00288	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—SMO—bone cancer	0.000274	0.00286	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR ligand binding—SMO—bone cancer	0.000273	0.00286	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR ligand binding—SMO—bone cancer	0.000273	0.00286	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A7—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000272	0.00285	CbGpPWpGaD
Dinoprost Tromethamine—Hypotension—Methotrexate—bone cancer	0.000272	0.00215	CcSEcCtD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—GRM1—bone cancer	0.000272	0.00284	CbGpPWpGaD
Dinoprost Tromethamine—Loss of consciousness—Doxorubicin—bone cancer	0.000271	0.00214	CcSEcCtD
Dinoprost Tromethamine—Infection—Epirubicin—bone cancer	0.00027	0.00213	CcSEcCtD
Dinoprost Tromethamine—Cough—Doxorubicin—bone cancer	0.000269	0.00213	CcSEcCtD
Dinoprost Tromethamine—Shock—Epirubicin—bone cancer	0.000268	0.00211	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Doxorubicin—bone cancer	0.000267	0.00211	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Doxorubicin—bone cancer	0.000266	0.0021	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Epirubicin—bone cancer	0.000266	0.0021	CcSEcCtD
Dinoprost Tromethamine—GALR3—Signaling Pathways—GRM4—bone cancer	0.000265	0.00277	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—RGS1—bone cancer	0.000265	0.00277	CbGpPWpGaD
Dinoprost Tromethamine—Hyperhidrosis—Epirubicin—bone cancer	0.000263	0.00208	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Doxorubicin—bone cancer	0.000263	0.00207	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Methotrexate—bone cancer	0.000261	0.00206	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Doxorubicin—bone cancer	0.00026	0.00205	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Methotrexate—bone cancer	0.000259	0.00205	CcSEcCtD
Dinoprost Tromethamine—SLC22A11—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000259	0.00271	CbGpPWpGaD
Dinoprost Tromethamine—Somnolence—Methotrexate—bone cancer	0.000259	0.00204	CcSEcCtD
Dinoprost Tromethamine—PTGFR—GPCR downstream signaling—RGS1—bone cancer	0.000258	0.0027	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR downstream signaling—GRM4—bone cancer	0.000258	0.0027	CbGpPWpGaD
Dinoprost Tromethamine—Hypotension—Epirubicin—bone cancer	0.000254	0.00201	CcSEcCtD
Dinoprost Tromethamine—PTGER1—GPCR downstream signaling—GRM4—bone cancer	0.000253	0.00264	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR downstream signaling—RGS1—bone cancer	0.000253	0.00264	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR downstream signaling—GRM4—bone cancer	0.000253	0.00264	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR downstream signaling—RGS1—bone cancer	0.000253	0.00264	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—GNA11—bone cancer	0.00025	0.00262	CbGpPWpGaD
Dinoprost Tromethamine—Infection—Doxorubicin—bone cancer	0.00025	0.00198	CcSEcCtD
Dinoprost Tromethamine—GALR3—GPCR downstream signaling—IL3—bone cancer	0.00025	0.00262	CbGpPWpGaD
Dinoprost Tromethamine—Pain—Methotrexate—bone cancer	0.000249	0.00196	CcSEcCtD
Dinoprost Tromethamine—Shock—Doxorubicin—bone cancer	0.000248	0.00196	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Doxorubicin—bone cancer	0.000246	0.00194	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Epirubicin—bone cancer	0.000244	0.00193	CcSEcCtD
Dinoprost Tromethamine—PTGIR—Hemostasis—SPARC—bone cancer	0.000244	0.00255	CbGpPWpGaD
Dinoprost Tromethamine—Hyperhidrosis—Doxorubicin—bone cancer	0.000243	0.00192	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Epirubicin—bone cancer	0.000243	0.00192	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Epirubicin—bone cancer	0.000242	0.00191	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Methotrexate—bone cancer	0.00024	0.00189	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Methotrexate—bone cancer	0.000238	0.00188	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Doxorubicin—bone cancer	0.000235	0.00186	CcSEcCtD
Dinoprost Tromethamine—SLC22A7—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000235	0.00246	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—RGS1—bone cancer	0.000234	0.00245	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—GRM4—bone cancer	0.000234	0.00245	CbGpPWpGaD
Dinoprost Tromethamine—Pain—Epirubicin—bone cancer	0.000233	0.00184	CcSEcCtD
Dinoprost Tromethamine—HPGDS—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	0.00023	0.00241	CbGpPWpGaD
Dinoprost Tromethamine—Abdominal pain—Methotrexate—bone cancer	0.00023	0.00182	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Methotrexate—bone cancer	0.00023	0.00182	CcSEcCtD
Dinoprost Tromethamine—GALR3—Signaling Pathways—GRM1—bone cancer	0.00023	0.0024	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—GRM4—bone cancer	0.000229	0.0024	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—GRM4—bone cancer	0.000229	0.0024	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—RGS1—bone cancer	0.000229	0.0024	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—RGS1—bone cancer	0.000229	0.0024	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A8—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000229	0.00239	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—IL3—bone cancer	0.000227	0.00237	CbGpPWpGaD
Dinoprost Tromethamine—Paraesthesia—Doxorubicin—bone cancer	0.000226	0.00179	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Doxorubicin—bone cancer	0.000225	0.00177	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Epirubicin—bone cancer	0.000224	0.00177	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Doxorubicin—bone cancer	0.000224	0.00177	CcSEcCtD
Dinoprost Tromethamine—PTGFR—GPCR downstream signaling—GRM1—bone cancer	0.000224	0.00234	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—GNA11—bone cancer	0.000223	0.00234	CbGpPWpGaD
Dinoprost Tromethamine—Gastrointestinal pain—Epirubicin—bone cancer	0.000223	0.00176	CcSEcCtD
Dinoprost Tromethamine—PTGIR—GPCR downstream signaling—GRM1—bone cancer	0.000219	0.00229	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR downstream signaling—GRM1—bone cancer	0.000219	0.00229	CbGpPWpGaD
Dinoprost Tromethamine—Pain—Doxorubicin—bone cancer	0.000215	0.0017	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Epirubicin—bone cancer	0.000215	0.0017	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Epirubicin—bone cancer	0.000215	0.0017	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Methotrexate—bone cancer	0.000214	0.00169	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—GPCR downstream signaling—GNA11—bone cancer	0.000214	0.00224	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—SMO—bone cancer	0.000212	0.00222	CbGpPWpGaD
Dinoprost Tromethamine—Asthenia—Methotrexate—bone cancer	0.000209	0.00165	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Doxorubicin—bone cancer	0.000208	0.00164	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Doxorubicin—bone cancer	0.000206	0.00163	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Methotrexate—bone cancer	0.000206	0.00162	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—RGS1—bone cancer	0.000205	0.00215	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—GRM4—bone cancer	0.000205	0.00215	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—GRM1—bone cancer	0.000203	0.00213	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—IL3—bone cancer	0.000202	0.00212	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—PLAU—bone cancer	0.000201	0.0021	CbGpPWpGaD
Dinoprost Tromethamine—Hypersensitivity—Epirubicin—bone cancer	0.000201	0.00158	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Doxorubicin—bone cancer	0.000199	0.00157	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Doxorubicin—bone cancer	0.000199	0.00157	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Methotrexate—bone cancer	0.000199	0.00157	CcSEcCtD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—GRM1—bone cancer	0.000199	0.00208	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—GRM1—bone cancer	0.000199	0.00208	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A8—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000198	0.00207	CbGpPWpGaD
Dinoprost Tromethamine—Asthenia—Epirubicin—bone cancer	0.000195	0.00154	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—GNA11—bone cancer	0.000194	0.00203	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR downstream signaling—IL3—bone cancer	0.000194	0.00203	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	0.000193	0.00202	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR downstream signaling—GNA11—bone cancer	0.000193	0.00202	CbGpPWpGaD
Dinoprost Tromethamine—Pruritus—Epirubicin—bone cancer	0.000193	0.00152	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Methotrexate—bone cancer	0.000192	0.00152	CcSEcCtD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—SMO—bone cancer	0.000191	0.002	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	0.000191	0.002	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A6—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000191	0.002	CbGpPWpGaD
Dinoprost Tromethamine—Diarrhoea—Epirubicin—bone cancer	0.000186	0.00147	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Doxorubicin—bone cancer	0.000186	0.00146	CcSEcCtD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—GRM4—bone cancer	0.000185	0.00194	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—RGS1—bone cancer	0.000185	0.00194	CbGpPWpGaD
Dinoprost Tromethamine—Vomiting—Methotrexate—bone cancer	0.000185	0.00146	CcSEcCtD
Dinoprost Tromethamine—Rash—Methotrexate—bone cancer	0.000183	0.00145	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Methotrexate—bone cancer	0.000183	0.00145	CcSEcCtD
Dinoprost Tromethamine—Headache—Methotrexate—bone cancer	0.000182	0.00144	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Doxorubicin—bone cancer	0.000181	0.00143	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Epirubicin—bone cancer	0.00018	0.00142	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Doxorubicin—bone cancer	0.000178	0.00141	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—GRM1—bone cancer	0.000178	0.00186	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—IL3—bone cancer	0.000176	0.00184	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—GNA11—bone cancer	0.000175	0.00183	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR downstream signaling—IL3—bone cancer	0.000175	0.00183	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—ENO2—bone cancer	0.000173	0.00181	CbGpPWpGaD
Dinoprost Tromethamine—Vomiting—Epirubicin—bone cancer	0.000173	0.00137	CcSEcCtD
Dinoprost Tromethamine—Nausea—Methotrexate—bone cancer	0.000173	0.00136	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Doxorubicin—bone cancer	0.000172	0.00136	CcSEcCtD
Dinoprost Tromethamine—Rash—Epirubicin—bone cancer	0.000172	0.00135	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Epirubicin—bone cancer	0.000171	0.00135	CcSEcCtD
Dinoprost Tromethamine—Headache—Epirubicin—bone cancer	0.000171	0.00135	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Doxorubicin—bone cancer	0.000167	0.00131	CcSEcCtD
Dinoprost Tromethamine—SLC22A6—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000165	0.00172	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—SMO—bone cancer	0.000162	0.00169	CbGpPWpGaD
Dinoprost Tromethamine—Nausea—Epirubicin—bone cancer	0.000162	0.00128	CcSEcCtD
Dinoprost Tromethamine—HPGDS—Metabolism—DHFR—bone cancer	0.000161	0.00168	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—GRM1—bone cancer	0.000161	0.00168	CbGpPWpGaD
Dinoprost Tromethamine—Vomiting—Doxorubicin—bone cancer	0.00016	0.00126	CcSEcCtD
Dinoprost Tromethamine—SLC22A2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000159	0.00167	CbGpPWpGaD
Dinoprost Tromethamine—Rash—Doxorubicin—bone cancer	0.000159	0.00125	CcSEcCtD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—IL3—bone cancer	0.000159	0.00166	CbGpPWpGaD
Dinoprost Tromethamine—Dermatitis—Doxorubicin—bone cancer	0.000159	0.00125	CcSEcCtD
Dinoprost Tromethamine—Headache—Doxorubicin—bone cancer	0.000158	0.00125	CcSEcCtD
Dinoprost Tromethamine—HPGDS—Metabolism—GNA11—bone cancer	0.00015	0.00157	CbGpPWpGaD
Dinoprost Tromethamine—Nausea—Doxorubicin—bone cancer	0.00015	0.00118	CcSEcCtD
Dinoprost Tromethamine—GALR3—Signaling Pathways—GNA11—bone cancer	0.000148	0.00155	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR downstream signaling—GNA11—bone cancer	0.000144	0.00151	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—SMO—bone cancer	0.000143	0.0015	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR downstream signaling—GNA11—bone cancer	0.000141	0.00148	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR downstream signaling—GNA11—bone cancer	0.000141	0.00148	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—SMO—bone cancer	0.00014	0.00147	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—SMO—bone cancer	0.00014	0.00147	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—GRM4—bone cancer	0.000138	0.00145	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—RGS1—bone cancer	0.000138	0.00145	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—ATF1—bone cancer	0.000138	0.00144	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000137	0.00144	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—CYP3A4—bone cancer	0.000136	0.00143	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	0.000136	0.00142	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—GRM4—bone cancer	0.000136	0.00142	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—RGS1—bone cancer	0.000136	0.00142	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—GRM4—bone cancer	0.000136	0.00142	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—RGS1—bone cancer	0.000136	0.00142	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—IL3—bone cancer	0.000134	0.0014	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—PLAU—bone cancer	0.000133	0.00139	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—GNA11—bone cancer	0.000131	0.00137	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR downstream signaling—IL3—bone cancer	0.000131	0.00137	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	0.000129	0.00135	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—GNA11—bone cancer	0.000128	0.00134	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—GNA11—bone cancer	0.000128	0.00134	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR downstream signaling—IL3—bone cancer	0.000128	0.00134	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR downstream signaling—IL3—bone cancer	0.000128	0.00134	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	0.000126	0.00132	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—SMO—bone cancer	0.000125	0.00131	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—NDUFA12—bone cancer	0.000124	0.0013	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—GRM1—bone cancer	0.00012	0.00126	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—IL3—bone cancer	0.000119	0.00124	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—GRM1—bone cancer	0.000117	0.00123	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—GRM1—bone cancer	0.000117	0.00123	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—GSTP1—bone cancer	0.000117	0.00122	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—IL3—bone cancer	0.000116	0.00122	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—IL3—bone cancer	0.000116	0.00122	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—TGFBR2—bone cancer	0.000115	0.0012	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—GNA11—bone cancer	0.000115	0.0012	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—SMO—bone cancer	0.000113	0.00118	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—IGF1R—bone cancer	0.000108	0.00113	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—ATF1—bone cancer	0.000107	0.00112	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—IL3—bone cancer	0.000104	0.00109	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—GNA11—bone cancer	0.000103	0.00108	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—NT5C3A—bone cancer	0.000103	0.00108	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmission across Chemical Synapses—BRAF—bone cancer	0.000101	0.00106	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—ATF1—bone cancer	9.62e-05	0.00101	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—IL3—bone cancer	9.38e-05	0.000981	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—TGFBR2—bone cancer	8.89e-05	0.00093	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmission across Chemical Synapses—MDM2—bone cancer	8.46e-05	0.000885	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—SMO—bone cancer	8.46e-05	0.000885	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—IGF1R—bone cancer	8.37e-05	0.000875	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—SMO—bone cancer	8.28e-05	0.000866	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—SMO—bone cancer	8.28e-05	0.000866	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—TP53—bone cancer	8.09e-05	0.000846	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—TGFBR2—bone cancer	8.02e-05	0.000839	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—KIT—bone cancer	7.83e-05	0.000819	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Neuronal System—BRAF—bone cancer	7.74e-05	0.000809	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—GNA11—bone cancer	7.74e-05	0.000809	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—GNA11—bone cancer	7.57e-05	0.000792	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—GNA11—bone cancer	7.57e-05	0.000792	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—IGF1R—bone cancer	7.55e-05	0.00079	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—BRAF—bone cancer	7.36e-05	0.00077	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—ATF1—bone cancer	7.19e-05	0.000752	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—EGFR—bone cancer	7.13e-05	0.000746	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—ATF1—bone cancer	7.04e-05	0.000736	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—ATF1—bone cancer	7.04e-05	0.000736	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—IL3—bone cancer	7.01e-05	0.000734	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—IL3—bone cancer	6.86e-05	0.000718	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—IL3—bone cancer	6.86e-05	0.000718	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Neuronal System—MDM2—bone cancer	6.48e-05	0.000678	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—MDM2—bone cancer	6.16e-05	0.000645	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—KIT—bone cancer	6.07e-05	0.000635	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—PTGS2—bone cancer	6.04e-05	0.000632	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—TGFBR2—bone cancer	6e-05	0.000628	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—TGFBR2—bone cancer	5.87e-05	0.000614	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—TGFBR2—bone cancer	5.87e-05	0.000614	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—BRAF—bone cancer	5.7e-05	0.000597	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—IGF1R—bone cancer	5.64e-05	0.00059	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—EGFR—bone cancer	5.53e-05	0.000578	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—IGF1R—bone cancer	5.52e-05	0.000578	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—IGF1R—bone cancer	5.52e-05	0.000578	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—KIT—bone cancer	5.47e-05	0.000573	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—JUN—bone cancer	5.36e-05	0.00056	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—TP53—bone cancer	5.34e-05	0.000559	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—MMP9—bone cancer	5.21e-05	0.000545	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—BRAF—bone cancer	5.14e-05	0.000538	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—EGFR—bone cancer	4.99e-05	0.000522	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—MDM2—bone cancer	4.78e-05	0.0005	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—ENO2—bone cancer	4.52e-05	0.000473	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—MDM2—bone cancer	4.31e-05	0.000451	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—EGFR—bone cancer	4.21e-05	0.000441	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—DHFR—bone cancer	4.19e-05	0.000438	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—JUN—bone cancer	4.15e-05	0.000435	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—KIT—bone cancer	4.09e-05	0.000428	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—MMP9—bone cancer	4.04e-05	0.000423	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—KIT—bone cancer	4.01e-05	0.000419	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—KIT—bone cancer	4.01e-05	0.000419	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—GNA11—bone cancer	3.92e-05	0.00041	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—BRAF—bone cancer	3.85e-05	0.000402	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—BRAF—bone cancer	3.77e-05	0.000394	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—BRAF—bone cancer	3.77e-05	0.000394	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—JUN—bone cancer	3.75e-05	0.000392	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—EGFR—bone cancer	3.73e-05	0.00039	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—EGFR—bone cancer	3.65e-05	0.000382	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—EGFR—bone cancer	3.65e-05	0.000382	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—MMP9—bone cancer	3.65e-05	0.000381	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—CYP3A4—bone cancer	3.55e-05	0.000372	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—TP53—bone cancer	3.54e-05	0.00037	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—EGFR—bone cancer	3.27e-05	0.000342	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—MDM2—bone cancer	3.22e-05	0.000337	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—MDM2—bone cancer	3.15e-05	0.00033	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—MDM2—bone cancer	3.15e-05	0.00033	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—GSTP1—bone cancer	3.04e-05	0.000318	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—EGFR—bone cancer	2.95e-05	0.000308	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—JUN—bone cancer	2.8e-05	0.000293	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—JUN—bone cancer	2.74e-05	0.000287	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—JUN—bone cancer	2.74e-05	0.000287	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—TP53—bone cancer	2.74e-05	0.000287	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—MMP9—bone cancer	2.73e-05	0.000285	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—MMP9—bone cancer	2.67e-05	0.000279	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—MMP9—bone cancer	2.67e-05	0.000279	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—TP53—bone cancer	2.47e-05	0.000259	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—EGFR—bone cancer	2.2e-05	0.00023	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—EGFR—bone cancer	2.16e-05	0.000226	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—EGFR—bone cancer	2.16e-05	0.000226	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—TP53—bone cancer	1.85e-05	0.000193	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—TP53—bone cancer	1.81e-05	0.000189	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—TP53—bone cancer	1.81e-05	0.000189	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—PTGS2—bone cancer	1.57e-05	0.000165	CbGpPWpGaD
